FindMyKOL

Prakriti Gaba, MD

Basic profile

Brigham and Women's Hospital

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionBoston, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceverified 2026Payments2021 onwardNIH fundingNot yet indexedWhy? →

Prakriti Gaba is a Cardiology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 90 publications with 2,085 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
90publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

2,085citations

Citations across these publications.

21h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Medtronic, Inc.
    Program year202510 payments
    $18,638
  • AstraZeneca UK Limited
    Program year20251 payment
    $21
  • Chiesi USA, Inc.
    Program year20251 payment
    $14
All 10 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    71.7%
    Statin30.4%
    Atorvastatin Calcium100%
    Part D≥14 patients
    Beta blocker23.2%
    Metoprolol Succinate100%
    Part D≥11 patients

    + 2 more classes in this area

  • Blood & clotting

    18.1%
    Factor Xa inhibitor9.4%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor8.7%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    10.1%
    GLP-1 receptor agonist10.1%
    Ozempic100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/PrakritiGaba

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”